Sort
23,748 grants matching “melanoma”
LKB1 tumor suppressor and human cancer
$829,961Diego H Castrillon · Ut Southwestern Medical Center · U01 · FY2010 · CA
Building better T cell receptors for targeted immunotherapy
$828,987Brian M Baker · University Of Notre Dame · R01 · FY2019 · AI
Determining the Fate of Transmembrane Proteins
$828,622Allan M Weissman · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Mouse Models of Skin Cancer
$828,552Susan M Fischer · University Of Tx Md Anderson Can Ctr · U01 · FY2008 · CA
A Novel Microbiome-Based Immune-Modulator that Potentiates Cancer Checkpoint Therapy
$828,114Gary Fanger · Rise Therapeutics, Llc · R44 · FY2023 · CA
Roles of NADPH Oxidase 5 and Dual Oxidase 2 in Cancer
$828,009James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Role of Tumor Stroma in Therapeutic Response and Resistance
$827,411Phillip Andrew Futreal · University Of Tx Md Anderson Can Ctr · U54 · FY2014 · CA
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$826,436Ze'ev A Ronai · Cedars-Sinai Medical Center · R35 · FY2024 · CA
Development of Physiologic Tissue Models to Assess Tumor Explant Response to Immune Checkpoint Blockade
$826,420Roger D. Kamm · Massachusetts Institute Of Technology · U01 · FY2021 · CA
MACROMOLECULAR STRUCTURE DETERMINATION - GENERAL USERS
$826,218Robert M Sweet · Brookhaven Science Assoc-Brookhaven Lab · P41 · FY2009 · RR
Developing new immunotherapies based of CD4 T cells
$826,167Nicholas Restifo · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Mouse Models of Skin Cancer
$826,068Susan M Fischer · University Of Tx Md Anderson Can Ctr · U01 · FY2006 · CA
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations
$825,019James R. Heath · Institute For Systems Biology · U54 · FY2022 · CA
LKB1 tumor suppressor and human cancer
$825,000Diego H Castrillon · Ut Southwestern Medical Center · U01 · FY2009 · CA
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
$824,443Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Missouri Valley Cancer Consortium CCOP
$823,998Missouri Valley Cancer Consortium, Inc. · U10 · FY2004 · CA
Clinical evaluation of combination oncolytic viro-immunotherapy for solid tumors
$823,919Luke O. Russell · Vyriad, Inc. · R44 · FY2020 · CA
High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy
$823,919Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Mouse Models of Skin Cancer
$823,782University Of Texas Md Anderson Can Ctr · U01 · FY2005 · CA
A PROSPECTIVE STUDY OF DIET AND CANCER IN WOMEN
$823,745Brigham And Women'S Hospital · R01 · FY2000 · CA
Immune checkpoints in the CNS and HIV-associated neurocognitive disorder
$823,691Qigui Yu · Indiana University Indianapolis · R56 · FY2023 · NS
Clinical production of viral vectors for cancer gene therapy
$823,336Rachel Beyer · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Mouse Models of Skin Cancer
$823,278Susan M Fischer · University Of Tx Md Anderson Can Ctr · U01 · FY2007 · CA
The Role of Transcription Factor Isoforms in Eye and Neural Crest Development
$821,631Heinz Arnheiter · National Institute Of Neurological Disorders And Stroke · ZIA · FY2009 · NS
Project 1: Analysis of cell autonomous mechanisms of phenotypic switching in invasive cancer models
$820,613Andre Levchenko · Yale University · U54 · FY2016 · CA